1LOKICH J J, MOORE C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome [J]. Ann Intern Med,1984,101(6) :798-799.
2BLUM J L, JONES S E, BUZDAR A U, et al. Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast caneer[J]. J Clin Oneol, 1999,17 (2): 485-493.
7OLVER I N, AISNER J,HAMENT A, et al. A prospective study of topical Dimetyl sulfoxide for treating anthracycline extravasation [J]. J Clin Oncol, 1988, 6 (11):1732-1735.
8[1]Budman DR, Meropol NJ, Reiger B, et al. Preliminary studies of a novel fluoropyrimidine carbamate: Capecitabine [J]. J Clin Oncol, 1998, 16: 1795-1802.
9[2]Mackean MJ, Planting AS, Twelves C, et al. A Phase I and pharmacologic study of intermittent twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer [J]. J Clin Oncol, 1998, 16: 2977-2985.
10Meta analysis group in cancer.Toxicity of fluorouracil inpatients with advanced colorectal cancer:Effect of asministion schdule and prognostic factors[J].J Clin Oncol,1998,16:3 537.